Hillsdale Investment Management Inc. Xeris Biopharma Holdings, Inc. Transaction History
Hillsdale Investment Management Inc.
- $3 Billion
- Q3 2025
A detailed history of Hillsdale Investment Management Inc. transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Hillsdale Investment Management Inc. holds 1,000 shares of XERS stock, worth $7,250. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,000
Previous 1,100
9.09%
Holding current value
$7,250
Previous $6,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding XERS
# of Institutions
236Shares Held
94.1MCall Options Held
251KPut Options Held
61.8K-
Black Rock Inc. New York, NY10.3MShares$74.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.83MShares$71.3 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY5.84MShares$42.3 Million0.03% of portfolio
-
Geode Capital Management, LLC Boston, MA4.14MShares$30 Million0.0% of portfolio
-
State Street Corp Boston, MA3.74MShares$27.1 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $986M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...